Clinigen Group (CLIN)

 

CLIN Share PerformanceMore

52 week high1,187.0 01/11/17
52 week low807.5 27/04/17
52 week change 70.5 (8.67%)
4 week volume6,475,811 30/03/18
price883.5
price date1524674628
close906.0

Latest NewsMore

The UK smaller companies that stock pickers love

Fears that Brexit would hurt smaller companies have been shrugged off, with the sector beating all comers. Rebecca Jones...

Clinigen Group appointed by Jazz to distribute Vyxeos outside the United States

Clinigen Group announced Monday that it has been appointed by Jazz Pharmaceuticals to distribute Vyxeos liposome thro...

Clinigen and Jazz Pharma initiate MA programme

RNS Number: 0522I Clinigen Group plc 19 March 2018 RNS Reach 19 March 2018 Clinigen appointed by Jazz Pharmaceuticals to manage Managed Access Program for Vyxeos (CPX-351) outside the United States Clinigen Group plc (AIM: CLIN, 'Clinigen'), the global pharmaceutical and services company, has been appointed by Jazz Pharmaceuticals plc (NASDAQ: JA...

Holding(s) in Company

RNS Number: 7574G Clinigen Group plc 05 March 2018 TR-1: S tandard form for notification of major holdings NOTIFICATION OF MAJOR HOLDINGS (to be sent to the relevant issuer and to the FCA in Microsoft Word format if possible) i 1a. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached ii: Clinigen Group Plc...

Grant of Share Options and PDMR notification

RNS Number: 9352F Clinigen Group plc 01 March 2018 1 March 2018 Grant of Share Options and PDMR notification Clinigen Group plc (AIM: CLIN, "Clinigen" or the "Company" ) , announces that, on 1 March 2018, Debra Ainge (Chief Operating Officer of the Company and a PDMR) was granted share options over a total of 17,888 ordinary shares of 0.1 pence each ...

Half year results

RNS Number: 9831F Clinigen Group plc 27 February 2018 27 February 2018 GOOD H1 PERFORMANCE WITH ADJUSTED EPS UP 13% Clinigen Group plc (AIM: CLIN, 'Clinigen' or 'the Group'), the global pharmaceuticals and services group, has today published its half year results for the six months ended 31 December 2017. FINANCIAL SUMMARY Six months e...

Notice of Results

RNS Number: 0247E Clinigen Group plc 06 February 2018 6 February 2018 Notification of half year results date Clinigen Group plc ('Clinigen' or the 'Group', AIM: CLIN), the global pharmaceutical and services company, will announce its half year results for the six months ended 31 December 2017 on Tuesday, 27 February 2018. A group analyst briefing will be held ...

Broker Forecast - Berenberg issues a broker note on Clinigen Group

Berenberg today upgrades its investment rating on Clinigen Group (LON:CLIN) to buy (from hold) and raised its price tar...

Fundamental DataMore

P/E ratio267.727
EPS3.3
Dividend yield0.566 %

Latest discussion posts More

  • Re: garbage

    even worse than garbage. cant wait to get out of this one.. heres hoping this gets near the eleven mark, but it looks like it is more likely to go the other way as far as ...
    25-Apr-2018
    up protherics
  • garbage

    I see this pile of cr......................p is falling again... I wonder what price quantum wuld be now.. probably double what they were taken over for
    17-Apr-2018
    up protherics
  • Just a thought

    It may simply be down to half the city not being able to get to work during the past few days due to weather.Thus not making a proper market in the shares Also This weather ...
    1-Mar-2018
    up protherics

Users' HoldingsMore

Users who hold Clinigen Group also hold..

Codes & Symbols

ISINGB00B89J2419
SymbolsCLIN, LSE:CLIN, CLIN.L, CLIN:LN, LON:CLIN, XLON:CLIN